期刊文献+

青壮年甲状腺功能亢进患者的骨代谢特征 被引量:4

Bone metabolism characteristics of young patients with hyperthyroidism
暂未订购
导出
摘要 目的通过对初发的青壮年甲状腺功能亢进症(甲亢)患者的骨密度(BMD)的测定,研究甲亢患者骨代谢的特征。方法采用双能X线吸收法对我院369例初发未经治疗的青壮年甲亢患者组和148名健康对照组进行腰椎L2-4,股骨近端的BMD检测,同时测定甲状腺功能、AKP、PTH、CT、24 h尿钙、血钙等。结果比较甲亢组与健康对照组的FT3、FT4和TSH差异有统计学意义(P<0.01),甲亢组的血钙、PTH和CT与对照组比较无统计学差异(P>0.05);甲亢骨量正常组24 h尿钙与对照组比较差异无统计学意义(P>0.05),而甲亢骨量异常组24 h尿钙与对照组比较有显著性差异(P<0.05);甲亢患者BMD与血清FT3、FT4呈负相关,与TSH呈正相关。结论通过甲状腺功能、骨密度及骨代谢指标的研究分析,发现甲亢将导致青壮年骨量减少和骨质疏松,因此在治疗甲亢时,不应忽略对骨质疏松的预防。 Objective To study the characteristics of bone metabolism by detecting bone mineral density (BMD) of young patients with hyperthyroidism. Methods The BMD of lumbar L2-4 and proximal femur in 369 cases of untreated patients with hyperthyroidism and 148 healthy controls were detected by dual-energy X-ray absorptiometry. The thyroid function, AKP, PTH, CT, 24 h urinary calcium, serum calcium were also detected. Results Comparison of FT3, FT4 and TSH between hyperthyroidism group and control group, which had statistically significant difference (P0.05). There were no significant difference of 24 h urine calcium in hyperthyroidism bone mass normal group and control group (P〉0.05). And 24 h urine calcium in hyperthyroidism abnormal bone mass group and the control group were significant difference (P〈0.05). The BMD were negatively correlated with serum FT3, FT4 in hyperthyroidism patients, and positively correlated with TSH. Conclusion It was found that hyperthyroidism could cause bone loss and osteoporosis in young adults through the analysis of thyroid function, BMD and bone metabolism. So the prevention of osteoporosis should not be ignored in the treatment of hyperthyroidism..
出处 《分子诊断与治疗杂志》 2013年第6期382-384,共3页 Journal of Molecular Diagnostics and Therapy
基金 云南省卫生科技计划资助项目(2010NS010)
关键词 甲状腺功能亢进症 骨密度 双能X线吸收法 Hyperthyroidism Bone density Dual energy X-ray absorptiometry
  • 相关文献

参考文献5

二级参考文献27

  • 1李景学.骨矿物质影像学研究的新趋向[J].中华放射学杂志,1996,30(1):56-58. 被引量:17
  • 2王维力.内分泌性骨质疏公症[A].刘忠厚 主编.骨质疏松学[C].北京:科学出版社,1998.558-565.
  • 3[1]Huang BK,Goloen LA,Tarjan G,et al.Insulin-like growth factor I production is essential for anabolic effects of thyroid hormone in osteoblasts. J Bone Miner Res,2000,15:188-197.
  • 4[2]Varga F,Rumpler M,Klaushofer K,et al.Thyroid hormones increase insulin-like growth factor mRNA levels in the clonal osteoblastic cell line MC3T3-E1.FEBS Lett ,1994,345:67-70.
  • 5[3]Lakatos P,Foldes J,Nagy Z,et al.Serum insulin-like growth factor-Ⅰ,insulin-like growth factor binding proteins, and bone mineral conternt in hyperthyroidism.Thyroid,2000,10:417-423.
  • 6[4]Abu EO,Bord S,Horner A,et al.The exrpession of thyroid hormone receptors in human bone. Bone ,1997,21:137-142.
  • 7[5]Allain TJ,Ten PM,Flanagan AM,et al.The isoform-specific expression of the tri-iodothyronine receptor in osteoblasts and osteoclasts.Eur J Clin Invest,1996,26:418-425.
  • 8[6]Siddiqi A, Burrim JM, Noonan K, et al. A longitudinal study of markers of bone turnover in Graves' disease and their value in predicting bone mineral density.J Clin Endocrinol Metab,1997,82:753-759.
  • 9[7]Pantazi H,Papapetrou PD.Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.J Clin Endorcinol Metab,2000,85:1099-1106.
  • 10[8]Lucidarme N,Ruiz JC,Czernichow P,et al.Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease. J Pediatr,2000,137:56-62.

共引文献71

同被引文献27

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部